Difference between revisions of "Part:BBa K4414037"
(15 intermediate revisions by 2 users not shown) | |||
Line 3: | Line 3: | ||
<partinfo>BBa_K4414037 short</partinfo> | <partinfo>BBa_K4414037 short</partinfo> | ||
− | This composite part consists of a C-terminal tetR(BBa_K4414009) domain and an | + | This composite part consists of a C-terminal tetR([[Part:BBa_K4414009]]) domain and an GR LBD([[Part:BBa_K4414000]]) domain fused with NES([[Part:BBa_K4414003]]). It is designed to sense glucocorticoids and activates the transcription of the reporter gene. |
==Usage and Biology== | ==Usage and Biology== | ||
− | As a glucocorticoid sensor, this part is designed to enter the nucleus upon glucocorticoid stimulation and bind to the TCE promoter to activate downstream transcription. This part consists of a tetR DNA binding domain, which binds to the TCE promoter (BBa_K4016011) consisting of seven direct 19-bp tet operator sequence (tetO) repeats. The | + | As a glucocorticoid sensor, this part is designed to enter the nucleus upon glucocorticoid stimulation and bind to the TCE promoter to activate downstream transcription. This part consists of a tetR DNA binding domain, which binds to the TCE promoter ([[Part:BBa_K4016011]]) consisting of seven direct 19-bp tet operator sequence (tetO) repeats. The GR LBD domain on the N terminal is the ligand binding domain of the glucocorticoid receptor(GR). This LBD domain can translocate the fusion protein into the nucleus upon glucocorticoid stimulation. It also has a transactivating domain 2 (τ2) and an activation function domain 2 (AF2) which activates downstream gene expression(Weikum, Knuesel, Ortlund, & Yamamoto, 2017). NES is a nuclear export signal which can translocate protein from the nucleus into the cytosol . |
Line 16: | Line 16: | ||
<figure class="figure"> | <figure class="figure"> | ||
− | <img src="https://static.igem.wiki/teams/4414/wiki/037-1.png" class="figure-img img-fluid rounded" height=" | + | <img src="https://static.igem.wiki/teams/4414/wiki/037-1.png" class="figure-img img-fluid rounded" height="350px"> |
</figure> | </figure> | ||
Line 22: | Line 22: | ||
</html> | </html> | ||
− | Figure1. Figure1. Schematic figure of BBa_K4414037 and BBa_K4414041 | + | Figure1. Figure1. Schematic figure of BBa_K4414037 and ([[Part:BBa_K4414041]]) |
Line 38: | Line 38: | ||
==Functional Validation== | ==Functional Validation== | ||
+ | |||
+ | HEK-293T cells were co-transfected with plasmids encoding both BBa_K4414037 and TCE-SEAP([[Part:BBa_K4414041]]). | ||
===Method=== | ===Method=== | ||
− | + | Cells were treated with 100 nM Glucocorticoids 6 h post-transfection. Cells without glucocorticoid treatment were used as control. Culture medium was collected at 24 h or 48 h post glucocorticoids treatment. SEAP activity was measured according to a published protocol (Shao, Qiu, & Xie, 2021). | |
+ | |||
<html> | <html> | ||
<figure class="figure"> | <figure class="figure"> | ||
− | <img src="https://static.igem.wiki/teams/4414/wiki/37-2.png" class="figure-img img-fluid rounded" height=" | + | <img src="https://static.igem.wiki/teams/4414/wiki/37-2.png" class="figure-img img-fluid rounded" height="350px"> |
</figure> | </figure> | ||
</html> | </html> | ||
− | Figure 2 | + | |
+ | Figure 2:Cotransfected our plasmid with the TCE-SEAP into cells | ||
Line 58: | Line 62: | ||
<figure class="figure"> | <figure class="figure"> | ||
− | <img src="https://static.igem.wiki/teams/4414/wiki/ | + | <img src="https://static.igem.wiki/teams/4414/wiki/nudt2022-037-3.png" class="figure-img img-fluid rounded" height="350px"> |
</figure> | </figure> | ||
Line 65: | Line 69: | ||
Figure3. Glucocorticoid-stimulated transcriptional activation of SEAP mediated by BBa_K4414037. | Figure3. Glucocorticoid-stimulated transcriptional activation of SEAP mediated by BBa_K4414037. | ||
− | Results showed | + | Results showed increased SEAP expression in glucocorticoid-treated cells compared to the non-treated control (1.7-2.0 folds). A dose dependence was observed within 0-100 nM of glucocorticoid (Figure 3). |
===Reference=== | ===Reference=== | ||
− | + | 1. Weikum, E. R., Knuesel, M. T., Ortlund, E. A., & Yamamoto, K. R. (2017). Glucocorticoid receptor control of transcription: precision and plasticity via allostery. Nat Rev Mol Cell Biol, 18(3), 159-174. doi:10.1038/nrm.2016.152 | |
− | + | ||
+ | 2. Shao, J., Qiu, X., & Xie, M. (2021). Engineering Mammalian Cells to Control Glucose Homeostasis. Methods Mol Biol, 2312, 35-57. doi:10.1007/978-1-0716-1441-9_3 |
Latest revision as of 17:55, 11 October 2022
TetR-GSG-NES-GSG-LBD
This composite part consists of a C-terminal tetR(Part:BBa_K4414009) domain and an GR LBD(Part:BBa_K4414000) domain fused with NES(Part:BBa_K4414003). It is designed to sense glucocorticoids and activates the transcription of the reporter gene.
Usage and Biology
As a glucocorticoid sensor, this part is designed to enter the nucleus upon glucocorticoid stimulation and bind to the TCE promoter to activate downstream transcription. This part consists of a tetR DNA binding domain, which binds to the TCE promoter (Part:BBa_K4016011) consisting of seven direct 19-bp tet operator sequence (tetO) repeats. The GR LBD domain on the N terminal is the ligand binding domain of the glucocorticoid receptor(GR). This LBD domain can translocate the fusion protein into the nucleus upon glucocorticoid stimulation. It also has a transactivating domain 2 (τ2) and an activation function domain 2 (AF2) which activates downstream gene expression(Weikum, Knuesel, Ortlund, & Yamamoto, 2017). NES is a nuclear export signal which can translocate protein from the nucleus into the cytosol .
Figure1. Figure1. Schematic figure of BBa_K4414037 and (Part:BBa_K4414041)
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Functional Validation
HEK-293T cells were co-transfected with plasmids encoding both BBa_K4414037 and TCE-SEAP(Part:BBa_K4414041).
Method
Cells were treated with 100 nM Glucocorticoids 6 h post-transfection. Cells without glucocorticoid treatment were used as control. Culture medium was collected at 24 h or 48 h post glucocorticoids treatment. SEAP activity was measured according to a published protocol (Shao, Qiu, & Xie, 2021).
Figure 2:Cotransfected our plasmid with the TCE-SEAP into cells
Result
The test results are as follows: Figure3. Glucocorticoid-stimulated transcriptional activation of SEAP mediated by BBa_K4414037.
Results showed increased SEAP expression in glucocorticoid-treated cells compared to the non-treated control (1.7-2.0 folds). A dose dependence was observed within 0-100 nM of glucocorticoid (Figure 3).
Reference
1. Weikum, E. R., Knuesel, M. T., Ortlund, E. A., & Yamamoto, K. R. (2017). Glucocorticoid receptor control of transcription: precision and plasticity via allostery. Nat Rev Mol Cell Biol, 18(3), 159-174. doi:10.1038/nrm.2016.152
2. Shao, J., Qiu, X., & Xie, M. (2021). Engineering Mammalian Cells to Control Glucose Homeostasis. Methods Mol Biol, 2312, 35-57. doi:10.1007/978-1-0716-1441-9_3